NCT01920672View on ClinicalTrials.gov

Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Alzheimer's Disease
Interventions
BEHAVIORAL

Timed Planned Activity

BEHAVIORAL

Home Safety and Education Program

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Johns Hopkins University

OTHER

NCT01920672 - Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD | Biotech Hunter | Biotech Hunter